305 related articles for article (PubMed ID: 22870571)
1. Black Medicaid beneficiaries experience breast cancer treatment delays more frequently than whites.
Balasubramanian BA; Demissie K; Crabtree BF; Strickland PA; Pawlish K; Rhoads GG
Ethn Dis; 2012; 22(3):288-94. PubMed ID: 22870571
[TBL] [Abstract][Full Text] [Related]
2. Socioeconomic disparities in breast cancer treatment among older women.
White A; Richardson LC; Krontiras H; Pisu M
J Womens Health (Larchmt); 2014 Apr; 23(4):335-41. PubMed ID: 24350590
[TBL] [Abstract][Full Text] [Related]
3. Racial differences in adjuvant systemic therapy for early breast cancer among Medicaid beneficiaries.
Balasubramanian BA; Demissie K; Crabtree BF; Ohman Strickland PA; Kohler B; Rhoads GG
Breast J; 2010; 16(2):162-8. PubMed ID: 20030647
[TBL] [Abstract][Full Text] [Related]
4. Racial variation in breast cancer treatment among Department of Defense beneficiaries.
Enewold L; Zhou J; McGlynn KA; Anderson WF; Shriver CD; Potter JF; Zahm SH; Zhu K
Cancer; 2012 Feb; 118(3):812-20. PubMed ID: 21766298
[TBL] [Abstract][Full Text] [Related]
5. Disparities in Breast Cancer Survival by Socioeconomic Status Despite Medicare and Medicaid Insurance.
Silber JH; Rosenbaum PR; Ross RN; Reiter JG; Niknam BA; Hill AS; Bongiorno DM; Shah SA; Hochman LL; Even-Shoshan O; Fox KR
Milbank Q; 2018 Dec; 96(4):706-754. PubMed ID: 30537364
[TBL] [Abstract][Full Text] [Related]
6. Differences in treatment and survival among African-American and Caucasian women with early stage operable breast cancer.
Sail K; Franzini L; Lairson D; Du X
Ethn Health; 2012; 17(3):309-23. PubMed ID: 22066691
[TBL] [Abstract][Full Text] [Related]
7. Racial/Ethnic differences in receipt of timely adjuvant therapy for older women with breast cancer: are delays influenced by the hospitals where patients obtain surgical care?
Freedman RA; He Y; Winer EP; Keating NL
Health Serv Res; 2013 Oct; 48(5):1669-83. PubMed ID: 23663229
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with receipt of breast cancer adjuvant chemotherapy in a diverse population-based sample.
Griggs JJ; Hawley ST; Graff JJ; Hamilton AS; Jagsi R; Janz NK; Mujahid MS; Friese CR; Salem B; Abrahamse PH; Katz SJ
J Clin Oncol; 2012 Sep; 30(25):3058-64. PubMed ID: 22869890
[TBL] [Abstract][Full Text] [Related]
9. Racial Differences in Extremity Soft Tissue Sarcoma Treatment in a Universally Insured Population.
Pak LM; Kwon NK; Baldini EH; Learn PA; Koehlmoos T; Haider AH; Raut CP
J Surg Res; 2020 Jun; 250():125-134. PubMed ID: 32044509
[TBL] [Abstract][Full Text] [Related]
10. Racial disparities in omission of oncotype DX but no racial disparities in chemotherapy receipt following completed oncotype DX test results.
Press DJ; Ibraheem A; Dolan ME; Goss KH; Conzen S; Huo D
Breast Cancer Res Treat; 2018 Feb; 168(1):207-220. PubMed ID: 29181717
[TBL] [Abstract][Full Text] [Related]
11. Race and ethnicity and breast cancer outcomes in an underinsured population.
Komenaka IK; Martinez ME; Pennington RE; Hsu CH; Clare SE; Thompson PA; Murphy C; Zork NM; Goulet RJ
J Natl Cancer Inst; 2010 Aug; 102(15):1178-87. PubMed ID: 20574040
[TBL] [Abstract][Full Text] [Related]
12. Racial differences in receipt of adjuvant hormonal therapy among Medicaid enrollees in South Carolina diagnosed with breast cancer.
Felder TM; Do DP; Lu ZK; Lal LS; Heiney SP; Bennett CL
Breast Cancer Res Treat; 2016 May; 157(1):193-200. PubMed ID: 27120468
[TBL] [Abstract][Full Text] [Related]
13. Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study.
Felix AS; Cohn DE; Brasky TM; Zaino R; Park K; Mutch DG; Creasman WT; Thaker PH; Walker JL; Moore RG; Lele SB; Guntupalli SR; Downs LS; Nagel CI; Boggess JF; Pearl ML; Ioffe OB; Randall ME; Brinton LA
Am J Obstet Gynecol; 2018 Nov; 219(5):459.e1-459.e11. PubMed ID: 30096321
[TBL] [Abstract][Full Text] [Related]
14. Delays in adjuvant chemotherapy treatment among patients with breast cancer are more likely in African American and Hispanic populations: a national cohort study 2004-2006.
Fedewa SA; Ward EM; Stewart AK; Edge SB
J Clin Oncol; 2010 Sep; 28(27):4135-41. PubMed ID: 20697082
[TBL] [Abstract][Full Text] [Related]
15. Residual treatment disparities after oncology referral for rectal cancer.
Morris AM; Billingsley KG; Hayanga AJ; Matthews B; Baldwin LM; Birkmeyer JD
J Natl Cancer Inst; 2008 May; 100(10):738-44. PubMed ID: 18477800
[TBL] [Abstract][Full Text] [Related]
16. A tracking and feedback registry to reduce racial disparities in breast cancer care.
Bickell NA; Shastri K; Fei K; Oluwole S; Godfrey H; Hiotis K; Srinivasan A; Guth AA
J Natl Cancer Inst; 2008 Dec; 100(23):1717-23. PubMed ID: 19033569
[TBL] [Abstract][Full Text] [Related]
17. Patterns of care analysis among women with ductal carcinoma in situ in North Carolina.
Jackson LC; Camacho F; Levine EA; Anderson RT; Stewart JH
Am J Surg; 2008 Feb; 195(2):164-9. PubMed ID: 18096124
[TBL] [Abstract][Full Text] [Related]
18. Disparities in pancreas cancer care.
Abraham A; Al-Refaie WB; Parsons HM; Dudeja V; Vickers SM; Habermann EB
Ann Surg Oncol; 2013 Jun; 20(6):2078-87. PubMed ID: 23579872
[TBL] [Abstract][Full Text] [Related]
19. Racial differences in definitive breast cancer therapy in older women: are they explained by the hospitals where patients undergo surgery?
Keating NL; Kouri E; He Y; Weeks JC; Winer EP
Med Care; 2009 Jul; 47(7):765-73. PubMed ID: 19536008
[TBL] [Abstract][Full Text] [Related]
20. Race and Insurance Differences in the Receipt of Adjuvant Chemotherapy Among Patients With Stage III Colon Cancer.
Murphy CC; Harlan LC; Warren JL; Geiger AM
J Clin Oncol; 2015 Aug; 33(23):2530-6. PubMed ID: 26150445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
